/Companies

Starget Pharma

Shreveport, US · Founded 2025 · Delaware corporation · 1 known investors

Find your way into Starget Pharma

Sign up to see every warm intro you have to Starget Pharma

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Starget Pharma team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Early-stage clinical company developing Smart Targeted Radioligands for precision oncology of hard-to-heal cancers.

Founders & leadership

SK
Sigal Kalmanson CusnirExecutive

Board

RK
Ronen KalmansonBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$16.4M disclosed across 1 of 2 rounds · 2024–2026

▶$16.4MraisedFeb 2026 · 29 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ronen KalmansonDirector
  • Sigal Kalmanson CusnirExecutive Officer
Offering amount
$22.2M
Amount sold
$16.4M
Minimum investment
$50K
First sale
Jan 2026
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Starget Pharma do?
Early-stage clinical company developing Smart Targeted Radioligands for precision oncology of hard-to-heal cancers.
Who are Starget Pharma's investors?
Starget Pharma's investors include Cancer Focus.
How much funding has Starget Pharma raised?
Starget Pharma has disclosed $16.4M raised across 1 of its 2 known rounds.
Where is Starget Pharma headquartered?
Starget Pharma is headquartered in Shreveport, US.